Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Purovitalis is a Netherlands-based longevity company that specializes in the development and distribution of high-purity nutraceuticals designed to promote healthy aging. The company is best known for its focus on NAD+ restoration, offering products such as Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR). Purovitalis distinguishes itself in the market by utilizing advanced liposomal delivery technology to significantly improve the bioavailability and absorption of its supplements. Their product portfolio also includes evidence-based compounds like Resveratrol, Spermidine, and Quercetin, all of which are third-party tested for purity and quality. By bridging the gap between cutting-edge geroscience and consumer health, Purovitalis provides accessible interventions for cellular health and metabolic support. The company operates primarily within the European market but maintains a global reach through its digital platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Purovitalis.